Drawing for M-SCREEN

USPTO serial 79325429

M-SCREEN

Reviewed by CopyMark Law Group

Reg. 6959437Status 700Registered
Filing date
Status date
Registration date
Jan 24, 2023
Examiner
POLZER, NATALIE M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with M-SCREEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kenya Williams

Kenya Williams Thermo Fisher Scientific5781 Van Allen WayCarlsbad, CA 92008United States

Goods and services

ClassDescriptionStatusFirst use
001Reagents for scientific or research use; diagnostic and biological reagents for scientific or research use; none of the aforementioned goods for use in the field of drug discoveryACTIVE—
005Reagents for medical or clinical use; calibrating solutions for diagnostic assays for medical diagnostic use; diluents for diagnostic assays for medical diagnostic use; preparations for use as control samples for diagnostic assays for medical diagnostic use; diagnostic agents, preparations and substances for medical purposes; reagents for medical use; biological and biochemical preparations in the form of antibodies and antibody derivatives for use in medical diagnostic testing in the fields of cancer, immunology, haematology; diagnostic and biological reagents for medical use; none of the aforementioned goods for use in the field of drug discoveryACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 12, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 12, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 12, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 21, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 23, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 2, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 2, 2023FIMPFINAL DISPOSITION PROCESSED—
Apr 24, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 24, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 24, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 8, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 8, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 19, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 5, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 5, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Oct 5, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 5, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 5, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 15, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 15, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 15, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 23, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 23, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 23, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 23, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 23, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 4, 2022RFNTREFUSAL PROCESSED BY IB—
Mar 15, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 15, 2022RFRRREFUSAL PROCESSED BY MPU—
Feb 16, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 15, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 10, 2022DOCKASSIGNED TO EXAMINER—
Nov 19, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 15, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 11, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance